NO971546D0 - Reumatoid artritt-middel inneholdende IL-6-antagonist som aktiv bestanddel - Google Patents
Reumatoid artritt-middel inneholdende IL-6-antagonist som aktiv bestanddelInfo
- Publication number
- NO971546D0 NO971546D0 NO971546A NO971546A NO971546D0 NO 971546 D0 NO971546 D0 NO 971546D0 NO 971546 A NO971546 A NO 971546A NO 971546 A NO971546 A NO 971546A NO 971546 D0 NO971546 D0 NO 971546D0
- Authority
- NO
- Norway
- Prior art keywords
- rheumatoid arthritis
- antagonist
- active ingredient
- agent containing
- arthritis agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24403594 | 1994-10-07 | ||
PCT/JP1995/001144 WO1996011020A1 (fr) | 1994-10-07 | 1995-06-07 | Medicament contre la polyarthrite rhumatoide contenant un antagoniste d'interleukine 6 comme principe actif |
Publications (3)
Publication Number | Publication Date |
---|---|
NO971546D0 true NO971546D0 (no) | 1997-04-04 |
NO971546L NO971546L (no) | 1997-06-04 |
NO321089B1 NO321089B1 (no) | 2006-03-13 |
Family
ID=17112746
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19971546A NO321089B1 (no) | 1994-10-07 | 1997-04-04 | Anvendelse av et interleukin-6 antistoff eller interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandling av unormal synovialcelle-vekst. |
NO20055446A NO20055446L (no) | 1994-10-07 | 2005-11-17 | Anvendelse av et interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandlingav kronisk reumatoid artritt |
NO2009009C NO2009009I2 (no) | 1994-10-07 | 2009-05-04 | Tocilizumab |
NO2018017C NO2018017I1 (no) | 1994-10-07 | 2018-05-23 | Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055446A NO20055446L (no) | 1994-10-07 | 2005-11-17 | Anvendelse av et interleukin-6 reseptorantistoff for fremstilling av en farmasoytisk blanding for behandlingav kronisk reumatoid artritt |
NO2009009C NO2009009I2 (no) | 1994-10-07 | 2009-05-04 | Tocilizumab |
NO2018017C NO2018017I1 (no) | 1994-10-07 | 2018-05-23 | Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC |
Country Status (19)
Country | Link |
---|---|
EP (3) | EP0783893B1 (no) |
JP (1) | JP3067987B2 (no) |
KR (1) | KR100306517B1 (no) |
CN (2) | CN101601861A (no) |
AT (1) | ATE552012T1 (no) |
AU (1) | AU700819B2 (no) |
CA (1) | CA2201781C (no) |
CZ (1) | CZ296919B6 (no) |
DK (1) | DK0783893T3 (no) |
ES (1) | ES2384222T3 (no) |
FI (1) | FI120721B (no) |
HK (1) | HK1127497A1 (no) |
HU (1) | HU223602B1 (no) |
LU (1) | LU92048I2 (no) |
NO (4) | NO321089B1 (no) |
PL (1) | PL186506B1 (no) |
PT (1) | PT783893E (no) |
RU (1) | RU2147443C1 (no) |
WO (1) | WO1996011020A1 (no) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2312184T3 (es) * | 1997-03-21 | 2009-02-16 | Chugai Seiyaku Kabushiki Kaisha | Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas. |
WO1999008707A1 (fr) * | 1997-08-15 | 1999-02-25 | Chugai Seiyaku Kabushiki Kaisha | Preventifs et/ou medicaments contre le lupus erythemateux systemique, contenant un anticorps anti-recepteur d'il-6 comme ingredient actif |
CN100374159C (zh) | 1998-03-17 | 2008-03-12 | 中外制药株式会社 | 一种包含il-6拮抗剂活性成分的炎性肠道疾病的预防或治疗剂 |
AU3171199A (en) | 1998-04-17 | 1999-11-08 | Suntory Flowers Limited | Gene encoding protein having aurone synthesizing activity |
CN1259973C (zh) | 2000-10-25 | 2006-06-21 | 中外制药株式会社 | 含有il-6拮抗剂作为有效成分的牛皮癣的预防或治疗剂 |
WO2002066063A1 (fr) * | 2001-02-23 | 2002-08-29 | Nippon Organon K.K. | Traitements de maladies osseuses metaboliques |
UA80091C2 (en) * | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
EP3192528A1 (en) | 2002-02-14 | 2017-07-19 | Chugai Seiyaku Kabushiki Kaisha | Formulation of anti-il6r antibody-containing solutions comprising a sugar as a stabilizer |
GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
JP2007104901A (ja) * | 2004-01-16 | 2007-04-26 | Astellas Pharma Inc | 関節リウマチ治療薬のスクリーニング法 |
ATE464908T1 (de) * | 2004-02-11 | 2010-05-15 | Warner Lambert Co | Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern |
AR048335A1 (es) | 2004-03-24 | 2006-04-19 | Chugai Pharmaceutical Co Ltd | Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo |
TWI671403B (zh) | 2005-03-31 | 2019-09-11 | 中外製藥股份有限公司 | 控制組裝之多肽的製造方法 |
PA8672101A1 (es) * | 2005-04-29 | 2006-12-07 | Centocor Inc | Anticuerpos anti-il-6, composiciones, métodos y usos |
WO2007043641A1 (ja) | 2005-10-14 | 2007-04-19 | Fukuoka University | 膵島移植における移植膵島障害抑制剤 |
BRPI0617664B8 (pt) | 2005-10-21 | 2021-05-25 | Chugai Pharmaceutical Co Ltd | uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio |
AR057582A1 (es) | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
EP3135298B1 (en) | 2006-01-27 | 2018-06-06 | Keio University | Therapeutic agents for diseases involving choroidal neovascularization |
US11046784B2 (en) | 2006-03-31 | 2021-06-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
WO2007114325A1 (ja) | 2006-03-31 | 2007-10-11 | Chugai Seiyaku Kabushiki Kaisha | 二重特異性抗体を精製するための抗体改変方法 |
CN101495146B (zh) | 2006-04-07 | 2012-10-17 | 国立大学法人大阪大学 | 肌肉再生促进剂 |
MX2008014804A (es) | 2006-06-02 | 2009-01-27 | Regeneron Pharma | Anticuerpos de afinidad elevada a receptor de il-6 humano. |
US8080248B2 (en) | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
MX2009001110A (es) | 2006-08-03 | 2009-05-11 | Vaccinex Inc | Anticuerpos monoclonales anti-il-6 y usos de los mismos. |
JP2010095445A (ja) * | 2006-12-27 | 2010-04-30 | Tokyo Medical & Dental Univ | Il−6アンタゴニストを有効成分とする炎症性筋疾患治療剤 |
TWI438208B (zh) | 2007-01-23 | 2014-05-21 | Chugai Pharmaceutical Co Ltd | 抑制慢性排斥反應之藥劑 |
CL2008002885A1 (es) | 2007-09-26 | 2010-07-02 | Chugai Pharmaceutical Co Ltd | Anticuerpo anti-receptor de interleucina-6 (il-6); y composicion farmaceutica que lo comprende |
MX369784B (es) | 2007-09-26 | 2019-11-21 | Chugai Pharmaceutical Co Ltd | Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr). |
PH12018501459A1 (en) | 2007-09-26 | 2019-11-11 | Chugai Pharmaceutical Co Ltd | Modified antibody constant region |
EP2236604B1 (en) | 2007-12-05 | 2016-07-06 | Chugai Seiyaku Kabushiki Kaisha | Anti-nr10 antibody and use thereof |
DK2708559T3 (en) | 2008-04-11 | 2018-06-14 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of repeatedly binding two or more antigen molecules |
ES2564635T3 (es) | 2008-05-13 | 2016-03-28 | Novimmune Sa | Anticuerpos anti-IL-6/IL-6R y métodos de uso de los mismos |
KR101665729B1 (ko) * | 2008-06-05 | 2016-10-12 | 국립연구개발법인 고쿠리츠간켄큐센터 | 신경침윤 억제제 |
US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
JP5787446B2 (ja) | 2009-03-19 | 2015-09-30 | 中外製薬株式会社 | 抗体定常領域改変体 |
JP5717624B2 (ja) | 2009-03-19 | 2015-05-13 | 中外製薬株式会社 | 抗体定常領域改変体 |
AR076875A1 (es) | 2009-05-15 | 2011-07-13 | Chugai Pharmaceutical Co Ltd | Anticuerpo contra receptor de la tirosina quinasa (anti-axl) |
WO2010133087A1 (en) * | 2009-05-18 | 2010-11-25 | The University Of Hong Kong | Compositions and methods for treating inflammatory arthritis |
EP2481752B1 (en) | 2009-09-24 | 2016-11-09 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant regions |
JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
TWI609698B (zh) | 2010-01-20 | 2018-01-01 | Chugai Pharmaceutical Co Ltd | 穩定化的含抗體溶液製劑 |
JP5889181B2 (ja) | 2010-03-04 | 2016-03-22 | 中外製薬株式会社 | 抗体定常領域改変体 |
WO2011149046A1 (ja) | 2010-05-28 | 2011-12-01 | 独立行政法人国立がん研究センター | 膵癌治療剤 |
DK2578231T3 (da) | 2010-05-28 | 2022-12-12 | Chugai Pharmaceutical Co Ltd | Antitumor-t-celle-reaktionsforstærker |
CN103476793A (zh) | 2010-11-08 | 2013-12-25 | 基因技术公司 | 皮下施用的抗-il-6受体抗体 |
EP2644698B1 (en) | 2010-11-17 | 2018-01-03 | Chugai Seiyaku Kabushiki Kaisha | Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
CN108715614A (zh) | 2010-11-30 | 2018-10-30 | 中外制药株式会社 | 与多分子的抗原重复结合的抗原结合分子 |
JP4987117B2 (ja) | 2010-12-27 | 2012-07-25 | 中外製薬株式会社 | Il−6アンタゴニストを有効成分として含有する血中mmp−3濃度低下剤 |
BR112013021526B1 (pt) | 2011-02-25 | 2021-09-21 | Chugai Seiyaku Kabushiki Kaisha | Polipeptídio variante, métodos para manter ou diminuir as atividades de ligação a fcgriia (tipo r) e fcgriia (tipo h) e aumentar a atividade de ligação a fcgriib de um polipeptídio e para a supressão da produção de um anticorpo contra um polipeptídio compreendendo a região fc do anticorpo, métodos para a produção do referido polipeptídio com atividades de ligação mantidas ou diminuídas e aumentada e para a produção suprimida de um anticorpo, composição farmacêutica e uso de um polipeptídio |
JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
TW201817745A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
EP2791169B1 (en) | 2011-12-16 | 2017-07-19 | Synthon Biopharmaceuticals B.V. | Compounds and methods for treating inflammatory diseases |
EP2878305B1 (en) | 2012-05-21 | 2017-07-19 | Korea Research Institute of Bioscience and Biotechnology | Pharmaceutical composition for use in preventing or treating stat3-mediated disease, comprising salvia plebeia r. br. extract or fraction thereof as active ingredient composition |
US10782290B2 (en) | 2013-06-11 | 2020-09-22 | National Center Of Neurology And Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy |
RU2758952C1 (ru) | 2013-09-27 | 2021-11-03 | Чугаи Сейяку Кабусики Кайся | Способ получения полипептидного гетеромультимера |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
JP6227191B1 (ja) | 2014-12-19 | 2017-11-08 | 中外製薬株式会社 | 抗ミオスタチン抗体、変異Fc領域を含むポリペプチド、および使用方法 |
LT3233921T (lt) | 2014-12-19 | 2021-12-10 | Chugai Seiyaku Kabushiki Kaisha | Anti-c5 antikūnai ir panaudojimo būdai |
KR102605798B1 (ko) | 2015-02-05 | 2023-11-23 | 추가이 세이야쿠 가부시키가이샤 | 이온 농도 의존적 항원 결합 도메인을 포함하는 항체, Fc 영역 개변체, IL-8에 결합하는 항체, 및 그들의 사용 |
TWI805046B (zh) | 2015-02-27 | 2023-06-11 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
WO2016159213A1 (ja) | 2015-04-01 | 2016-10-06 | 中外製薬株式会社 | ポリペプチド異種多量体の製造方法 |
PL3299810T3 (pl) | 2015-05-19 | 2021-12-13 | National Center Of Neurology And Psychiatry | Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm) |
WO2016195088A1 (ja) | 2015-06-04 | 2016-12-08 | 国立研究開発法人 国立精神・神経医療研究センター | Il-6阻害剤を有効成分とする精神疾患治療剤 |
TWI786636B (zh) | 2015-11-03 | 2022-12-11 | 法商賽諾菲生物技術公司 | 用於治療葡萄膜炎及黃斑水腫之包含il6r抗體的組合物與其使用方法 |
JP7141336B2 (ja) | 2015-12-25 | 2022-09-22 | 中外製薬株式会社 | 抗ミオスタチン抗体および使用方法 |
KR20180091918A (ko) | 2015-12-28 | 2018-08-16 | 추가이 세이야쿠 가부시키가이샤 | Fc 영역 함유 폴리펩타이드의 정제를 효율화하기 위한 방법 |
CA3016424A1 (en) | 2016-03-14 | 2017-09-21 | Chugai Seiyaku Kabushiki Kaisha | Cell injury inducing therapeutic drug for use in cancer therapy |
JP6527643B2 (ja) | 2016-08-05 | 2019-06-05 | 中外製薬株式会社 | Il−8関連疾患の治療用又は予防用組成物 |
CN108339118A (zh) * | 2017-01-23 | 2018-07-31 | 瑞阳(苏州)生物科技有限公司 | 治疗或预防阻塞性睡眠呼吸暂停的药物组合物 |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
MX2020002750A (es) | 2017-09-13 | 2020-07-20 | Jiangsu Hengrui Medicine Co | Anticuerpo il-6r y fragmento de union a antigeno y uso medico. |
KR20200074160A (ko) | 2017-10-20 | 2020-06-24 | 가꼬우호우징 효고 이카다이가쿠 | 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물 |
CA3110891A1 (en) | 2018-08-29 | 2020-03-05 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for treating subjects having rheumatoid arthritis |
CN109517064B (zh) * | 2018-10-10 | 2020-05-08 | 北京汇智和源生物技术有限公司 | 白介素-6的人源化单克隆抗体、其编码基因及应用 |
US11498969B2 (en) | 2019-01-31 | 2022-11-15 | Sanofi Biotechnology | Compositions and methods for treating juvenile idiopathic arthritis |
WO2020178193A1 (en) | 2019-03-01 | 2020-09-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method of treatment of sarcoidosis |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341152C (en) | 1988-01-22 | 2000-12-12 | Tadamitsu Kishimoto | Receptor protein for human b cell stimulatory factor-2 |
EP0399429A1 (en) * | 1989-05-22 | 1990-11-28 | Toray Industries, Inc. | Anti-human interleukin-6 monoclonal antibody |
SG42954A1 (en) * | 1989-07-20 | 1997-10-17 | Tadamitsu Kishimoto | Antibody to human interleukin-6 receptor |
JP2898064B2 (ja) | 1989-08-03 | 1999-05-31 | 忠三 岸本 | ヒトgp130蛋白質 |
DE3939706C1 (no) * | 1989-12-01 | 1991-03-21 | Centre Regional De Transfusion Sanguine, Besancon, Fr | |
WO1991007986A1 (en) * | 1989-12-04 | 1991-06-13 | Schering Corporation | Method of treating septic shock |
JP2898040B2 (ja) | 1990-01-26 | 1999-05-31 | 忠三 岸本 | gp130蛋白質に対する抗体 |
US5210075A (en) | 1990-02-16 | 1993-05-11 | Tanabe Seiyaku Co., Ltd. | Interleukin 6 antagonist peptides |
JPH0489433A (ja) | 1990-07-27 | 1992-03-23 | Hitachi Chem Co Ltd | 免疫調節剤 |
JP2947924B2 (ja) * | 1990-11-21 | 1999-09-13 | 信和化工株式会社 | 光学異性体用分離剤 |
JPH04187645A (ja) | 1990-11-22 | 1992-07-06 | Chuzo Kishimoto | インターロイキン―6作用抑制剤 |
WO1992019759A1 (en) | 1991-04-25 | 1992-11-12 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
JPH05300338A (ja) | 1992-04-17 | 1993-11-12 | Ricoh Co Ltd | 複合機 |
JPH05304986A (ja) * | 1992-04-28 | 1993-11-19 | Tosoh Corp | gp130蛋白質に対するモノクロ−ナル抗体 |
FR2694767B1 (fr) * | 1992-08-13 | 1994-10-21 | Innotherapie Lab Sa | Anticorps monoclonaux anti-IL6R, et leurs applications. |
JPH06134617A (ja) | 1992-10-23 | 1994-05-17 | Amada Co Ltd | 鋸盤の鋸刃テンション自動調整装置 |
JP3525221B2 (ja) * | 1993-02-17 | 2004-05-10 | 味の素株式会社 | 免疫抑制剤 |
-
1995
- 1995-06-07 RU RU97108276A patent/RU2147443C1/ru active Protection Beyond IP Right Term
- 1995-06-07 CA CA002201781A patent/CA2201781C/en not_active Expired - Lifetime
- 1995-06-07 CZ CZ0103497A patent/CZ296919B6/cs not_active IP Right Cessation
- 1995-06-07 ES ES95921130T patent/ES2384222T3/es not_active Expired - Lifetime
- 1995-06-07 AT AT95921130T patent/ATE552012T1/de active
- 1995-06-07 EP EP95921130A patent/EP0783893B1/en not_active Expired - Lifetime
- 1995-06-07 DK DK95921130.1T patent/DK0783893T3/da active
- 1995-06-07 WO PCT/JP1995/001144 patent/WO1996011020A1/ja active IP Right Grant
- 1995-06-07 CN CNA2009101322726A patent/CN101601861A/zh active Pending
- 1995-06-07 EP EP09000787A patent/EP2077120A3/en not_active Withdrawn
- 1995-06-07 PL PL95319574A patent/PL186506B1/pl unknown
- 1995-06-07 HU HU9701906A patent/HU223602B1/hu active Protection Beyond IP Right Term
- 1995-06-07 KR KR1019970702209A patent/KR100306517B1/ko not_active IP Right Cessation
- 1995-06-07 PT PT95921130T patent/PT783893E/pt unknown
- 1995-06-07 CN CN2008102100070A patent/CN101361972B/zh not_active Expired - Lifetime
- 1995-06-07 EP EP09009350A patent/EP2107070A1/en not_active Withdrawn
- 1995-06-07 AU AU26303/95A patent/AU700819B2/en not_active Expired
- 1995-10-06 JP JP7284364A patent/JP3067987B2/ja not_active Expired - Lifetime
-
1997
- 1997-04-04 NO NO19971546A patent/NO321089B1/no not_active IP Right Cessation
- 1997-04-04 FI FI971404A patent/FI120721B/fi not_active IP Right Cessation
-
2005
- 2005-11-17 NO NO20055446A patent/NO20055446L/no not_active Application Discontinuation
-
2009
- 2009-05-04 NO NO2009009C patent/NO2009009I2/no unknown
- 2009-06-10 HK HK09105189.1A patent/HK1127497A1/xx not_active IP Right Cessation
-
2012
- 2012-07-20 LU LU92048C patent/LU92048I2/fr unknown
-
2018
- 2018-05-23 NO NO2018017C patent/NO2018017I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971546L (no) | Reumatoid artritt-middel inneholdende IL-6-antagonist som aktiv bestanddel | |
DK1108435T3 (da) | Forebyggende midler eller midler mod pancreatitis indeholdende anti-IL-6-receptor-antistoffer som den aktive bestanddel | |
ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
DK1334731T3 (da) | Forebyggende eller terapeutisk middel mod psoriasis omfattende anti-IL-6-receptorantistof som aktiv bestanddel | |
FI925615A (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
FI921606A (fi) | Mikroperoxidas innehaollande hemopeptid som aktiv komponent. | |
ES2172657T3 (es) | Inhibidores de trombina. | |
DK0601386T3 (da) | Sulfonamider | |
RU97108276A (ru) | Лечебные средства против хронического ревматоидного артрита, содержащие антагонист il-6 в качестве эффективного компонента | |
ATE225772T1 (de) | Thrombin-inhibitoren | |
KR960013371A (ko) | 약학적 혼합물 | |
DK0840606T3 (da) | Små di- og trivalente molekyler som selectininhibitorer | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
ATE332145T1 (de) | Arzneien zur begleitenden behandlung von glaukomen | |
DK144685A (da) | Substituerede benzopyraner, fremgangsmaader til fremstilling deraf samt deres anvendelse i laegemidler | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
ATE208402T1 (de) | Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren | |
FI894653A (fi) | Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare. | |
IT1265647B1 (it) | Composizione farmaceutiche topiche per le allergie respiratorie | |
ATE333287T1 (de) | Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten | |
EA199600048A3 (ru) | N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции | |
ITTO930018A0 (it) | Dispositivo di controllo attivo delle vibrazioni periodiche generate da un motore. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: ROACTEMRA - TOCILIZUMAB; REG. NO/DATE: EU108492001-006 20090206 Spc suppl protection certif: 2009009 Filing date: 20090504 Extension date: 20200607 |
|
MK1K | Patent expired | ||
SPCE | Application to extend a supplementary protection certificate (spc) |
Free format text: PRODUCT NAME: INTERLEUKIN-6 (IL-6) RESEPTOR ANTISTOFF; NAT. REG. NO/DATE: EU/1/08/492/001/NO-006 20090116; FIRST REG. NO/DATE: EU/1/08/492/001-006 20090116 Spc suppl protection certif: 2018017 Filing date: 20180523 |
|
SPCY | Withdrawal, rejection or dismissal of a request for extension of a supplementary protection certificate |
Free format text: PRODUCT NAME: INTERLEUKIN-6 (IL-6) RESEPTOR ANTISTOFF Spc suppl protection certif: 2018017 |
|
SPCX | Expiry of an spc |
Free format text: PRODUCT NAME: TOCILIZUMAB Spc suppl protection certif: 2009009 Effective date: 20200607 |